Demo Sign up Log In

Coherus Oncology Inc (CHRS)

Cash Conversion Ratio

5.82×

Quarterly · Period ending: Jun 30, 2026

CHRS Cash Conversion Ratio

Latest reported5.82×period endingJun 30, 2026

Latest reported5.82×period endingJun 30, 2026

CHRS Quarterly Cash Conversion Ratio (0.82× → 5.82×)

Latest values, visible window

High-resolution chart · PNG

CHRS cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	5.8153×
Mar 31, 2026	1.5258×
Dec 31, 2025	0.5289×
Sep 30, 2025	1.3199×
Jun 30, 2025	1.1281×
Mar 31, 2025	0.4565×
Dec 31, 2024	-0.5643×
Sep 30, 2024	5.7684×
Jun 30, 2024	-4.623×
Mar 31, 2024	-0.4546×
Dec 31, 2023	0.1628×
Sep 30, 2023	1.3698×
Jun 30, 2023	0.9101×
Mar 31, 2023	0.9096×
Dec 31, 2022	1.6993×
Sep 30, 2022	0.4333×
Jun 30, 2022	1.0153×
Mar 31, 2022	0.5689×
Dec 31, 2021	1.1545×
Sep 30, 2021	-0.3491×
Jun 30, 2021	0.0202×
Mar 31, 2021	-0.0071×
Dec 31, 2020	3.314×
Sep 30, 2020	1.6196×
Jun 30, 2020	0.9793×
Mar 31, 2020	0.3287×
Dec 31, 2019	0.4416×
Sep 30, 2019	1.1486×
Jun 30, 2019	0.5302×
Mar 31, 2019	2.8653×
Jun 30, 2017	1.0217×
Mar 31, 2017	1.0025×
Dec 31, 2016	1.1915×
Sep 30, 2016	-0.744×
Jun 30, 2016	0.3958×
Mar 31, 2016	1.2×
Dec 31, 2015	-0.0787×
Sep 30, 2015	0.8699×
Jun 30, 2015	0.3715×
Mar 31, 2015	0.8441×
Dec 31, 2014	1.1593×
Sep 30, 2014	0.7593×
Jun 30, 2014	0.0605×
Mar 31, 2014	-0.5755×
Dec 31, 2013	-0.3316×
Sep 30, 2013	-1×
Jun 30, 2013	0.4634×
Mar 31, 2013	0.8153×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.